Literature DB >> 18332102

Nischarin inhibits LIM kinase to regulate cofilin phosphorylation and cell invasion.

Yuemin Ding1, Tanja Milosavljevic, Suresh K Alahari.   

Abstract

Nischarin is a novel protein that regulates cell migration by inhibiting p21-activated kinase (PAK). LIM kinase (LIMK) is a downstream effector of PAK, and it is known to play an important role in cell invasion. Here we show that nischarin also associates with LIMK to inhibit LIMK activation, cofilin phosphorylation, and LIMK-mediated invasion of breast cancer cells, suggesting that nischarin regulates cell invasion by negative modulation of the LIMK/cofilin pathway. The amino terminus of nischarin binds to the PDZ and kinase domains of LIMK. Although LIMK activation enhances the interaction with nischarin, only phosphorylation of threonine 508 of LIMK is crucial for the interaction. Inhibition of endogenous nischarin expression by RNA interference stimulates breast cancer cell invasion. Also, nischarin small interfering RNA (siRNA) enhances cofilin phosphorylation. In addition, knock-down of nischarin showed branched projection actin structures. Collectively these data indicate that nischarin siRNA may enhance random migration, resulting in stimulation of invasion.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18332102      PMCID: PMC2423293          DOI: 10.1128/MCB.01832-07

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  63 in total

Review 1.  Pak to the future.

Authors:  S Bagrodia; R A Cerione
Journal:  Trends Cell Biol       Date:  1999-09       Impact factor: 20.808

2.  Regulation of LIM-kinase 1 and cofilin in thrombin-stimulated platelets.

Authors:  Dharmendra Pandey; Pankaj Goyal; James R Bamburg; Wolfgang Siess
Journal:  Blood       Date:  2005-10-11       Impact factor: 22.113

3.  Signaling from Rho to the actin cytoskeleton through protein kinases ROCK and LIM-kinase.

Authors:  M Maekawa; T Ishizaki; S Boku; N Watanabe; A Fujita; A Iwamatsu; T Obinata; K Ohashi; K Mizuno; S Narumiya
Journal:  Science       Date:  1999-08-06       Impact factor: 47.728

4.  The GIT-associated kinase PAK targets to the centrosome and regulates Aurora-A.

Authors:  Zhuo-Shen Zhao; Jet Phey Lim; Yuen-Wai Ng; Louis Lim; Ed Manser
Journal:  Mol Cell       Date:  2005-10-28       Impact factor: 17.970

Review 5.  Rho GTPases and the control of cell behaviour.

Authors:  A Hall
Journal:  Biochem Soc Trans       Date:  2005-11       Impact factor: 5.407

6.  The neurofibromatosis type 1 gene product neurofibromin enhances cell motility by regulating actin filament dynamics via the Rho-ROCK-LIMK2-cofilin pathway.

Authors:  Tatsuya Ozawa; Norie Araki; Shunji Yunoue; Hiroshi Tokuo; Liping Feng; Siriporn Patrakitkomjorn; Toshihiro Hara; Yasuko Ichikawa; Kunio Matsumoto; Kiyotaka Fujii; Hideyuki Saya
Journal:  J Biol Chem       Date:  2005-09-16       Impact factor: 5.157

7.  LIM kinase 1 increases tumor metastasis of human breast cancer cells via regulation of the urokinase-type plasminogen activator system.

Authors:  Rozita Bagheri-Yarmand; Abhijit Mazumdar; Aysegul A Sahin; Rakesh Kumar
Journal:  Int J Cancer       Date:  2006-06-01       Impact factor: 7.396

8.  Transmembrane neuregulins interact with LIM kinase 1, a cytoplasmic protein kinase implicated in development of visuospatial cognition.

Authors:  J Y Wang; K E Frenzel; D Wen; D L Falls
Journal:  J Biol Chem       Date:  1998-08-07       Impact factor: 5.157

9.  Inhibition of nischarin expression attenuates rilmenidine-evoked hypotension and phosphorylated extracellular signal-regulated kinase 1/2 production in the rostral ventrolateral medulla of rats.

Authors:  Jian Zhang; Abdel A Abdel-Rahman
Journal:  J Pharmacol Exp Ther       Date:  2007-10-16       Impact factor: 4.030

10.  Par-3 mediates the inhibition of LIM kinase 2 to regulate cofilin phosphorylation and tight junction assembly.

Authors:  Xinyu Chen; Ian G Macara
Journal:  J Cell Biol       Date:  2006-02-27       Impact factor: 10.539

View more
  34 in total

1.  Identifying transient protein-protein interactions in EphB2 signaling by blue native PAGE and mass spectrometry.

Authors:  Costel C Darie; Katrin Deinhardt; Guoan Zhang; Helene S Cardasis; Moses V Chao; Thomas A Neubert
Journal:  Proteomics       Date:  2011-10-28       Impact factor: 3.984

2.  Mutations in Vps15 perturb neuronal migration in mice and are associated with neurodevelopmental disease in humans.

Authors:  Thomas Gstrein; Andrew Edwards; Anna Přistoupilová; Ines Leca; Martin Breuss; Sandra Pilat-Carotta; Andi H Hansen; Ratna Tripathy; Anna K Traunbauer; Tobias Hochstoeger; Gavril Rosoklija; Marco Repic; Lukas Landler; Viktor Stránecký; Gerhard Dürnberger; Thomas M Keane; Johannes Zuber; David J Adams; Jonathan Flint; Tomas Honzik; Marta Gut; Sergi Beltran; Karl Mechtler; Elliott Sherr; Stanislav Kmoch; Ivo Gut; David A Keays
Journal:  Nat Neurosci       Date:  2018-01-08       Impact factor: 24.884

3.  Nischarin inhibition alters energy metabolism by activating AMP-activated protein kinase.

Authors:  Shengli Dong; Somesh Baranwal; Anapatricia Garcia; Silvia J Serrano-Gomez; Steven Eastlack; Tomoo Iwakuma; Donald Mercante; Franck Mauvais-Jarvis; Suresh K Alahari
Journal:  J Biol Chem       Date:  2017-08-24       Impact factor: 5.157

4.  Phosphorylation of cofilin-1 by ERK confers HDAC inhibitor resistance in hepatocellular carcinoma cells via decreased ROS-mediated mitochondria injury.

Authors:  P-H Liao; H-H Hsu; T-S Chen; M-C Chen; C-H Day; C-C Tu; Y-M Lin; F-J Tsai; W-W Kuo; C-Y Huang
Journal:  Oncogene       Date:  2016-10-17       Impact factor: 9.867

Review 5.  Understanding the role of integrins in breast cancer invasion, metastasis, angiogenesis, and drug resistance.

Authors:  Hassan Yousefi; Mousa Vatanmakanian; Mojdeh Mahdiannasser; Ladan Mashouri; Nikhilesh V Alahari; Mohammad Rafiee Monjezi; Shahrzad Ilbeigi; Suresh K Alahari
Journal:  Oncogene       Date:  2021-01-08       Impact factor: 9.867

6.  Molecular characterization of the tumor-suppressive function of nischarin in breast cancer.

Authors:  Somesh Baranwal; Yanfang Wang; Rajamani Rathinam; Jason Lee; Lianjin Jin; Robin McGoey; Yuliya Pylayeva; Filippo Giancotti; Gerard C Blobe; Suresh K Alahari
Journal:  J Natl Cancer Inst       Date:  2011-09-14       Impact factor: 13.506

Review 7.  Cofilin and profilin: partners in cancer aggressiveness.

Authors:  Joelle V F Coumans; Rhonda J Davey; Pierre D J Moens
Journal:  Biophys Rev       Date:  2018-07-19

8.  LIM kinase 1 deficient mice have reduced bone mass.

Authors:  Tsutomu Kawano; Meiling Zhu; Nancy Troiano; Mark Horowitz; Jessica Bian; Caren Gundberg; Katarzyna Kolodziejczak; Karl Insogna
Journal:  Bone       Date:  2012-09-24       Impact factor: 4.398

9.  Proteomic dissection of cell type-specific H2AX-interacting protein complex associated with hepatocellular carcinoma.

Authors:  Xiaoli Yang; Peng Zou; Jun Yao; Dong Yun; Huimin Bao; Ruyun Du; Jing Long; Xian Chen
Journal:  J Proteome Res       Date:  2010-03-05       Impact factor: 4.466

10.  Prooncogenic factors miR-23b and miR-27b are regulated by Her2/Neu, EGF, and TNF-α in breast cancer.

Authors:  Lianjin Jin; Oliver Wessely; Eric G Marcusson; Cristina Ivan; George A Calin; Suresh K Alahari
Journal:  Cancer Res       Date:  2013-01-21       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.